| Schedule of revenue recognition |
Revenue
by Service Line
| |
Three
Months Ended
September 30, |
|
| |
2019 |
|
|
2018 |
|
| Products: |
|
|
|
|
|
|
|
| Disposable
products: |
|
|
|
|
|
|
|
| Functional
neurosurgery |
$ |
1,854,251 |
|
|
$ |
1,448,850 |
|
| Biologics
and drug delivery |
|
491,257 |
|
|
|
190,993 |
|
| Therapy |
|
64,095 |
|
|
|
- |
|
| Capital
equipment |
|
184,825 |
|
|
|
99,961 |
|
| Total
product revenue |
|
2,594,428 |
|
|
|
1,739,804 |
|
| Services: |
|
|
|
|
|
|
|
| Capital
equipment and other |
|
210,538 |
|
|
|
62,238 |
|
| Biologics
and drug delivery |
|
72,500 |
|
|
|
5,000 |
|
| Therapy |
|
50,000 |
|
|
|
- |
|
| Total
service revenue |
|
333,038 |
|
|
|
67,238 |
|
| Total
revenue |
$ |
2,927,466 |
|
|
$ |
1,807,042 |
|
| |
Nine
Months Ended
September 30, |
|
| |
2019 |
|
|
2018 |
|
| Products: |
|
|
|
|
|
|
|
| Disposable
products: |
|
|
|
|
|
|
|
| Functional
neurosurgery |
$ |
5,212,460 |
|
|
$ |
3,787,712 |
|
| Biologics
and drug delivery |
|
957,673 |
|
|
|
483,251 |
|
| Therapy |
|
81,925 |
|
|
|
- |
|
| Capital
equipment |
|
700,517 |
|
|
|
420,039 |
|
| Total
product revenue |
|
6,952,575 |
|
|
|
4,691,002 |
|
| Services: |
|
|
|
|
|
|
|
| Capital
equipment and other |
|
515,695 |
|
|
|
218,742 |
|
| Biologics
and drug delivery |
|
335,500 |
|
|
|
167,000 |
|
| Therapy |
|
202,612 |
|
|
|
- |
|
| Total
service revenue |
|
1,053,807 |
|
|
|
385,742 |
|
| Total
revenue |
$ |
8,006,382 |
|
|
$ |
5,076,744 |
|
|